Active ingredientLasofoxifeneCat. No. P-L023-001CAS 180916-16-9Family · Pharmaceutical analytical standards
Lasofoxifene
A naphthalene-based selective oestrogen receptor modulator (SERM), authorised in the European Union in 2009 for postmenopausal osteoporosis; it was later also studied in breast cancer. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It binds the oestrogen receptor alpha with an affinity comparable to that of oestradiol, the natural hormone, and at least ten times higher than that of tamoxifen.
Go to the active ingredient →Active ingredientLasofoxifeneCat. No. P-L023-001CAS 180916-16-9
Active ingredientLasofoxifene SulfateCat. No. P-L023-002CAS 1048953-96-3
MetaboliteLasofoxifene glucuronideCat. No. P-L023-003CAS 1048953-95-2
Isotopically labelledLasofoxifene Impurity 1-d4Cat. No. P-L023-004
Isotopically labelledLasofoxifene-d4Cat. No. P-L023-005CAS 1126626-61-6
Isotopically labelledLasofoxifene-d5Cat. No. P-L023-006
Isotopically labelledrac-Lasofoxifene-d5Cat. No. P-L023-009
Impurity1-PyrrolidineethanolCat. No. P-L023-010CAS 2955-88-6
Impurityrac-Lasofoxifene-2-OxideCat. No. P-L023-011No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.